Joule Is On A Mission

To develop a battery-free wearable product with enhanced analytical and sensory capabilities that will transform...

November 1, 2016



Every year, only one-thirds of the 10 million physical therapy (PT) patients finish the recommended treatment. The suboptimal recovery causes chronic pain and, at worst, risks readmission for complicated procedures such as knee and hip replacement. With an average reimbursement of $800/patient, the noncompliance PT market represents a ~$2.4B opportunity for healthcare professionals and clinics. From talking to existing patients and therapists, Joule found that the majority of patients do not complete the required rehabilitation and physical therapy prescribed, citing proximity and transportation as a major inconvenience. By completing the required treatment on time, it not only increase the revenues of PT practices but also drastically reduces the re-injury rate of patients. One goal of our product is to fight non-consumption by creating an engaging digital analytics platform that opens the possibility of new telemedicine practice methodologies aimed at increasing patient compliance. Not only will our platform help with patient engagement and the rising telemedicine revolution, it will also provide patients with the predictive capabilities as they progress through the rehabilitation process - capabilities that are not available today.


From a competitive perspective, existing wearable technologies do not capture the most important PT parameters (e.g. range of motion). Existing battery technologies also impose power limitations on sensors in that they do not last long enough to allow for prolonged accuracy. Additionally, current medical and consumer sensors are limited to measuring acceleration and orientation for athletic training. They are not designed to measure the range and angle of movement for users in the physical therapy space.  Utilizing a NASA technology that is 10x more effective than current devices, we will be able to bridge the current technology gaps and improve the quality of care for PT patients. 


Joule's mission is to develop a battery-free wearable product with enhanced analytical and sensory capabilities that will transform PT rehab. The goal is to replace the manual, labor-intensive treatment with one that monitors recovery progress and engages patients over the entire rehab period to assess the quality of care. Of the technologies that do exist to capture this, none can sustain battery life long enough to be effective. Joule intends to revolutionize this space by harnessing power from the proprietary NASA technology in order to address the urgent need for accurate range-of-motion diagnostics in remote physical therapy. 



We thank The Center for Advancing Innovation for the opportunity and mentorship of our continued success.